Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N7IH
|
|||
Former ID |
DNC012151
|
|||
Drug Name |
N*1*-(6-Nitro-quinolin-2-yl)-ethane-1,2-diamine
|
|||
Synonyms |
CHEMBL38754; N*1*-(6-Nitro-quinolin-2-yl)-ethane-1,2-diamine; BDBM50090212; AKOS009510501
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H12N4O2
|
|||
Canonical SMILES |
C1=CC2=C(C=CC(=N2)NCCN)C=C1[N+](=O)[O-]
|
|||
InChI |
1S/C11H12N4O2/c12-5-6-13-11-4-1-8-7-9(15(16)17)2-3-10(8)14-11/h1-4,7H,5-6,12H2,(H,13,14)
|
|||
InChIKey |
ULJORSRDDXAXJZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Serotonin transporter (SERT) | Target Info | Inhibitor | [1] |
KEGG Pathway | Serotonergic synapse | |||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | 5HT1 type receptor mediated signaling pathway | |||
5HT2 type receptor mediated signaling pathway | ||||
5HT3 type receptor mediated signaling pathway | ||||
5HT4 type receptor mediated signaling pathway | ||||
WikiPathways | Monoamine Transport | |||
SIDS Susceptibility Pathways | ||||
NRF2 pathway | ||||
Synaptic Vesicle Pathway | ||||
Serotonin Transporter Activity |
References | Top | |||
---|---|---|---|---|
REF 1 | Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 1. Bioorg Med Chem Lett. 2000 Jul 17;10(14):1559-62. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.